Pipobroman
(Redirected from Vercyte)
An overview of the drug Pipobroman
Pipobroman | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Overview[edit | edit source]
Pipobroman is a chemotherapy drug used primarily in the treatment of certain types of blood cancer, including polycythemia vera and chronic myelogenous leukemia. It is classified as an alkylating agent, which means it works by interfering with the DNA replication process in rapidly dividing cells, such as cancer cells.
Mechanism of Action[edit | edit source]
Pipobroman exerts its effects by forming covalent bonds with the DNA of cancer cells. This action leads to the cross-linking of DNA strands, ultimately inhibiting DNA synthesis and function. As a result, the proliferation of cancer cells is reduced, leading to cell death. This mechanism is similar to other alkylating agents used in chemotherapy.
Uses[edit | edit source]
Pipobroman is primarily indicated for the treatment of:
- Polycythemia vera: A condition characterized by the overproduction of red blood cells.
- Chronic myelogenous leukemia (CML): A type of cancer that affects the bone marrow and blood.
Side Effects[edit | edit source]
Like many chemotherapy drugs, pipobroman can cause a range of side effects. Common side effects include:
- Myelosuppression: A decrease in the production of blood cells, leading to conditions such as anemia, leukopenia, and thrombocytopenia.
- Gastrointestinal disturbances: Such as nausea, vomiting, and diarrhea.
- Alopecia: Hair loss.
Administration[edit | edit source]
Pipobroman is administered orally in the form of tablets. The dosage and treatment schedule depend on the specific condition being treated and the patient's response to the medication.
Precautions[edit | edit source]
Patients receiving pipobroman should be monitored regularly for blood counts and signs of toxicity. It is important to adjust the dosage based on the patient's hematological response to avoid severe myelosuppression.
History[edit | edit source]
Pipobroman was developed as part of efforts to find effective treatments for blood cancers. Its use has been somewhat limited due to the availability of newer agents with more favorable side effect profiles.
Related pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD